Beacon Checkpoint

Benefit from the most complete clinical trial and drug landscape for immune checkpoint modulators

What we cover

Beacon Checkpoint is a sector-specific curated database that includes trial and drug records for preclinical, active, approved, and discontinued:

  • Immune Checkpoint Modulator Combinations
  • Immune Checkpoint Modulators Monotherapies
  • Across over 27 different checkpoint targets

How Beacon helps

Here are a few example use cases that have benefitted our clients in accelerating their checkpoint development programs:

  • Benchmark drug development and clinical trial strategies against competitors.
  • Get an in-depth overview of the landscape and insights into your competitors’ preclinical and clinical assets.
  • Drastically reduce manual research time with our database solution which allows users to rapidly assemble data for analysis on, line of therapy, clinical trial arms, disease indication, and much more.
  • Identify new players and new assets entering the clinic and monitor their progress.
  • Real time updates to help you keep abreast of new players, clinical entries and data releases.

How Beacon Checkpoint works

Use an intelligent search function to instantaneously sweep the clinical trial and drug landscapes using 20 search criteria including therapeutic class, target etc… Search for combinations in trials or individual arms to avoid false positives.

Key data points are presented in the results page and can be easily downloaded into Excel to run more complex analyses.

If publicly available, information regarding trials where an immune checkpoint is in combination with an antibody-drug conjugate, bispecific, cell therapy or gene therapy will also be included in our trial coverage.

How we source the data for Checkpoint Therapies

We house all publicly available sources of data updated with 24 – 48 hours of publication proactively.  Our sources cover (but are not limited to):

  • Clinical trials registries
  • Scientific journals and publications
  • Company reports and presentations
  • Press releases
  • Conference reports and abstracts
  • Government and regulatory organizations
  • Newspapers and other media
  • Patents

Related content

Checkpoint Thought Paper 2020

Find out more

Checkpoint Infographic 2020

Find out more

Bispecific and Checkpoint Infographic 2020

Find out more

What our customers say

"I’ve rarely seen such dedication from a service provider in understanding and responding to our needs"

Competitive Intelligence Manager
Top 20 Pharma

Our Checkpoint Expert

Ahmed Tajmohamed is the research analyst for Checkpoint in the Beacon Targeted Therapies team.

Sign up for our weekly newsletter with the latest Checkpoint landscape with data from Beacon Checkpoint.

Subscribe to newsletter

Other Beacon Solutions

ADC
Adoptive Cell
Bispecific
Cancer Vaccine
Cytokine
DDR
Gene Therapy
RNA
Oncolytic Viruses
TPD
Beacon ADC Logo

 

Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more

Find out more

Beacon Adoptive Cell Logo

 

Covering all engineered and non-engineered immune cell therapies, including CAR-T, TCR, NK, TILs, Gamma-Delta T Cells and more

Find out more

Beacon Bispecific Logo

 

Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more

Find out more

Cancer Vaccine Logo 2021

 

Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.

Find out more

 

Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families.

Find out more

Beacon DDR Logo

 

Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field.

Find out more

Beacon Gene Therapy Logo

 

From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used- Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks.

Find out more

 

Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.

Find out more

Beacon Oncolytic Viruses Logo

 

From capturing viral family and strains to understanding any genetic modifications – Beacon Oncolytic Viruses steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the Oncolytic Virus field.

Find out more

Beacon TPD Logo

 

Beacon TPD provides the solution you need to master the targeted protein degradation field.

Find out more

Any questions? Contact us

To learn more about how we can tailor Beacon Checkpoint to help you, get in touch with our sales team

Frank Plowden

 

Frank Plowden

Checkpoint Account Manager

Contact the Team

About Beacon Targeted Therapies

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.

logo